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SUMMARY
Introduction/Objective Biofilm and pyocyanin production are essential components of Pseudomonas 
aeruginosa virulence and antibiotic resistance.
Our objective was to examine inhibitory effect of synthetized propafenone derivatives 3-(2-Fluoro-
phenyl)-1-(2- (2-hydroxy-3-propylamino-propoxy)-phenyl)-propan-1-one hydrochloride (5OF) and3-(2-
Trifluoromethyl-phenyl)-1-(2-(2-hydroxy-3-propylamino-propoxy)-phenyl)-propan-1-one hydrochloride 
(5CF3) on biofilm and pyocyanin in Pseudomonas aeruginosa clinical strains.
Methods Effects were tested on nine clinical isolates and one control laboratory strain of P. aeruginosa. 
In vitro analysis of biofilm growing was performed by incubating bacteria (0.5 McFarland) with 5OF and 
5CF3 (500–31.2 µg/ml) and measuring optical density (OD) at 570 nm. Bacteria in medium without com-
pounds were positive control. Blank medium (an uninoculated medium without test compounds) was 
used as negative control. Pyocyanin production was estimated by OD at 520 nm, after bacteria incubated 
with 5CF3 and 5OF (250 and 500 μg/ml), treated with chloroform, and chloroform layer mixed with HCl. 
Results A total of 500 µg/ml of 5OF and 5CF3 completely inhibited biofilm formation in 10/10 and 4/10 
strains, respectively. A total of 250 µg/ml of 5OF and 5CF3 strongly inhibited biofilm formation in 7/10 
strains, while inhibition with 125 µg/ml of 5OF and 5CF3 was moderate. Lower concentrations had almost 
no effect on biofilm production. Pyocyanin production was reduced to less than 40% of the control value 
in 6/9, and less than 50% of the control in 7/9 strains with 500 μg/ml of 5OF and 5CF3, respectively. At 
250 µg/ml 5OF and 5CF3, most strains had pyocyanin production above 50% of the control value.
Conclusion Synthetized propafenone derivatives, 5OF and 5CF3, inhibited biofilms and pyocyanin produc-
tion of Pseudomonas aeruginosa clinical strains. Presented results suggest that propafenone derivatives 
are potential lead-compounds for synthesis of novel antipseudomonal drugs. 
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INTRODUCTION
As an opportunistic human pathogen, Pseudo-
monas aeruginosa has evolved a number of im-
munoevasive strategies to impair host defense, 
including growing in biofilm [1, 2]. 
Biofilms are bacterial clusters encased in 
self-produced polymeric matrix attached to 
the epithelial surfaces or surface of medical 
implants. They are characterized by lower met-
abolic activity, increased synthesis of protec-
tive molecules, prolonged doubling time, and 
genetic diversity of bacterial cells, all together 
improving bacterial tolerance to antibiotics 
and survival in harsh conditions [3, 4]. Bio-
film production in Pseudomonas aeruginosa is 
a well-known causative agent of antibiotic resis-
tant infections in humans, such as pneumonia, 
and infections in patients with bronchiectasis 
and cystic fibrosis [5, 6]. Due to resistance to 
phagocytosis and pronounced antibody re-
sponse, those infections lead to chronic inflam-
mation, often with a severe fatal outcome [7, 8]. 
Thus, there is an urgent need to develop new 
drugs for the treatment of Pseudomonas aeru-
ginosa biofilm-associated infections. In addi-
tion, Pseudomonas aeruginosa pathogenicity is 
intimately linked to its ability to produce large 
variety of virulence factors, including phen-
azine, and most abundant pyocyanin [9, 10]. 
Pyocyanin is highly diffusible blue pigment, 
which can interact with molecular oxygen and 
stimulate generation of oxygen radicals, leading 
to redox disbalance, injury and death of host 
cells [11]. As virulence factor in chronic lung 
infection pyocyanin disrupts redox control, 
inhibits respiration in human cells, accelerates 
neutrophil apoptosis, therefore impairing host 
defense and favoring bacterial persistence [12, 
13, 14]. 
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Considering that ion channels are integral part of each 
living cell, which play a key role in cell division, prolifera-
tion, excitation, and apoptosis, modulators of ion chan-
nel activity have become important target molecules in 
medical chemistry [15]. Propiophenone is relatively simple 
compound commercially obtained from benzoic and pro-
pionic acid, it has channel-modulatory effect and serve as a 
precursor of numerous drugs (e.g. ephedrine, arylalkene) 
[16, 17, 18]. Propiophenone derivatives called propafenone 
are primarily known on their antiarrhythmic action, but 
they are also involved in treatment of many different dis-
eases including lupus erythematosus, epilepsy, Alzheimer’s 
disease, malaria, ebola, cancer [19–25]. In addition, re-
cent studies have shown that analogs of propafenone ex-
hibit antifungal activity [26]. Therefore, the molecule of 
propafenone has become a model of compounds used in 
multidrug-resistant studies [27].
Since data on antibacterial activity of propafenone de-
rivatives are scarce, we decided to test potential antibac-
terial activity of 3-(2-Fluoro-phenyl)-1-(2- (2-hydroxy-
3-propylamino-propoxy)-phenyl)-propan-1-one hydro-
chloride (5OF) and 3-(2-Trifluoromethyl-phenyl)-1-(2-(2-
hydroxy-3-propylamino-propoxy)-phenyl)-propan-1-one 
hydrochloride (5CF3). Even more, because the influence 
of propafenone derivatives on the Pseudomonas aerugi-
nosa biofilm and pyocyanin production has not yet been 
tested, we expanded our examinations on the influence of 
propafenone derivatives on expression of Pseudomonas 
aeruginosa virulence factors.
In the present study, we aimed to evaluate the inhibitory 
effects of ortho-fluorinated propafenone derivatives, which 
were synthetized in our laboratory, on biofilm and pyocya-
nin production in Pseudomonas aeruginosa clinical strains. 
METHODS
Effect of ortho-fluorinated propafenone 
derivatives on the Pseudomonas aeruginosa 
biofilms 
Test compounds
Ortho-fluorinated propafenone derivatives were synthe-
sized at the Department of Pharmaceutical Chemistry, 
Faculty of Pharmacy, University of Belgrade, Serbia: 5CF3: 
3- (2-Trifluoromethyl-phenyl) -1- (2- (2-hydroxy-3-pro-
pylamino-propoxy) -phenyl) -propan-1-one hydrochloride 
and 5OF: 3- (2-Fluoro-phenyl) -1- (2- (2-hydroxy-3-pro-
pylamino-propoxy) -phenyl) -propan-1-one hydrochloride 
[28]. The structure of synthesized derivatives was spec-
trophotometrically analyzed at FT-IR spectrophotometer 
Nicolet iS10 (Thermo Fisher Scientific Inc., Waltham, MA, 
USA) [29].
The stock solutions of 5CF3 or 5OF (1 mg/ml) were 
prepared in 5% dimethyl sulfoxide (DMSO). The work-
ing solutions were prepared in trypticase soybean broth 
(TSB) with the addition of 1% glucose (Lab M Limited, 
Lancashire, UK) according to Knobloch et al. [30]. The 
concentrations of working solutions of 5CF3 or 5OF were 
31.2, 62.5, 125, 250, and 500 µg/ml. In previous stud-
ies, we already investigated antimicrobial effect of tested 
compounds in the concentration range from 500 μg/ml 
to 62.5 μg/ml, and the best activity was observed for 
250 μg/ml and 500 μg/ml of 5OF and 5CF3 [31].
Pseudomonas aeruginosa clinical isolates
The effects of tested compounds were investigated on nine 
clinical isolates obtained from urine (strains 1, 2, 5, 8, 9), 
ear swab (strains 3, 6, 7) or sputum (strain 4) and one labo-
ratory control strain (ATCC 27853). Bacteria were stored 
at -70°C in Brain Heart Infusion Broth (Lab M Limited) 
until needed. 
Culture medium
TSB and trypticase soybean agar (Lab M Limited) were 
used.
Analysis 
Biofilm production and quantification were performed 
according to protocols described by Stepanović et al. [32]. 
Briefly, bacteria were resuspended in saline to the density 
of a 0.5 McFarland standard (~108 CFU/ml). In 96 microti-
ter plates, 180 μl of test compounds and 20 μl of bacterial 
suspension were added in triplicate. Bacteria incubated 
in medium without test compounds were used as positive 
control, while blank medium (uninoculated medium with-
out test compounds) represented negative control. After 
incubation, which lasted 24h at 35°C, plates were washed 
in phosphate buffer (PBS, pH 7.2), dried, fixed with metha-
nol, and stained with 2% crystal violet (Himedia, Mumbai, 
India). After washing, the color was extracted from bacte-
ria with 96% ethanol. The OD was measured spectrophoto-
metrically at 570 nm (ICN Flow Titertek Multiscan Plus, 
ICN, USA). Each experiment was repeated three times. To 
calculate the category of biofilm production, the optical 
density cut-off (ODc) was determined as three standard 
deviations above the mean OD of the negative control. 
According to the calculated results, all tested strains were 
categorized into four groups: OD ≤ ODc - category 0 (no 
biofilm production); ODc < OD ≤ 2 × ODc - category 1 
(weak biofilm production); 2 × ODc < OD ≤ 4 × ODc - cat-
egory 2 (moderate biofilm production), and 4 × ODc < OD 
- category 3 (strong biofilm production).
Effect of ortho-fluorinated propafenone 
derivatives on the Pseudomonas aeruginosa 
pyocyanin production
Test compounds 
Ortho-fluorinated propafenone derivatives, 5CF3 and 5OF, 
were synthesized at the Department of Pharmaceutical 
Chemistry, Faculty of Pharmacy, University of Belgrade, 
Serbia.
Inhibitory effect of propafenone derivatives on Pseudomonas aeruginosa biofilm and pyocyanin production
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Working dilutions of 250 and 500 μg/ml 5CF3 and 5OF in 
5% DMSO were prepared from the stock solution of 1 mg/ml 
in 5% DMSO. Working concentrations were chosen based 
on our results about 5CF3 and 5OF effect on biofilm for-
mation, where concentrations of 250 μg/ml and 500 μg/ml 
appeared to have the strongest inhibitory effect.
Pseudomonas aeruginosa clinical strains
The effects of tested compounds were investigated on nine 
Pseudomonas aeruginosa clinical isolates. The sources of 
bacteria and storage conditions were the same as previ-
ously described in section Methods. 
Culture medium
Mueller–Hinton broth for bacteria (Torlak, Belgrade, Ser-
bia) was used (Figure 1).
Pyocyanin determination
Pyocyanin was determined as previously described by 
Glamočlija et al. [33]. Five milliliters of bacterial cultures 
in exponential phase of growth were incubated with test 
compounds for 24h at 37°C and then treated with 3 ml of 
chloroform. Separated chloroform layer was mixed with 
1 ml of 0.2 M HCl. OD was measured at 520 nm [34]. 
Positive controls for each isolate were cultivated at the 
same conditions in medium without tested compounds. 
Values were expressed as a ratio (OD520/OD600) × 100. Two 
experiments, each in triplicate, were performed. Results 
were calculated as the percent of the pyocyanin production 
compared to the positive control (expressed as 100% ± SD).
Statistical analysis
Obtained data were analyzed using statistical analysis soft-
ware package – SPSS Statistics Version 18.0 for Windows 
(SPSS Inc., Chicago, USA) and Student’s t-test [35]. 
RESULTS
Effect of ortho-fluorinated propafenone 
derivatives on the Pseudomonas aeruginosa 
biofilm formation
Ortho-fluorinated propafenone derivatives, 5OF and 5CF3, 
inhibited production of Pseudomonas aeruginosa biofilms. 
The intensity of inhibitory effects changed in concentra-
tion dependent manner, thus, higher drug concentrations 
lead to stronger inhibition. The highest inhibition occurred 
at concentration of 500 µg/ml of both compounds. When 
the 5OF and 5CF3 concentrations decreased to 250 µg/ml, 
125 µg/ml, 62.5 µg/ml, or 31.2 µg/ml, the inhibitory effect 
was also decreased. In addition, there was a variance in dif-
ferent isolates sensitivity to particular drug concentration. 
Biofilm formation was completely inhibited by 500 µg/ml 
of 5OF and 5CF3 in 10/10 and 4/10 strains, respectively. 
In 7/10 strains, biofilm formation was strongly inhibited 
by 250 µg/ml 5OF and 5CF3, while inhibition with 125 µg/
ml 5OF and 5CF3 was moderate. In the presence of lower 
5OF and 5CF3 concentrations, 62.5 µg/ml and 31.2, 8/10 
tested strains exerted strong biofilm production. Catego-
ries of biofilm production in different isolates and in the 
presence of various concentrations of tested compounds 
are presented in Table 1 and 2. 
Table 1. In vitro effect of 5OF on the biofilm production of Pseudo-
monas aeruginosa
Parameters
5OF µg/ml
500 250 125 62.5 31.2 Positive control
Pseudomonas 
aeruginosa 
Strain number
Category of biofilm production
1 0 1 2 2 2 2
2 0 1 1 3 3 3
3 0 0 1 2 2 2
4 0 1 1 3 3 3
5 0 1 2 3 3 3
6 0 1 2 3 3 3
7 0 2 2 3 3 3
8 0 1 2 3 3 3
9 0 1 1 2 3 3
ATCC 27853 0 0 2 3 3 3
5OF – 3- (2-fluoro-phenyl) -1- (2- (2-hydroxy-3-propylamino-propoxy) -phenyl) 
-propan-1-one hydrochloride; Positive control – bacterial growth in medium 
without tested compound; 0 – no biofilm production; 1 – weak biofilm 
production; 2 – moderate biofilm production; 3 – strong biofilm production
Table 2. In vitro effect of 5CF3 on the biofilm production of Pseudo-
monas aeruginosa
Parameters 5CF3 µg/ml
500 250 125 62.5 31.2 Positive  control
Pseudomonas 
aeruginosa 
Strain number
Category of biofilm production
1 0 1 2 2 2 2
2 1 1 2 3 3 3
3 0 1 2 2 2 2
4 1 2 2 3 3 3
5 1 1 2 3 3 3
6 0 1 2 3 3 3
7 1 2 2 3 3 3
8 1 1 3 3 3 3
9 1 2 2 3 3 3
ATCC 27853 0 1 0 3 3 3
5CF3 – 3- (2-trifluoromethyl-phenyl) -1- (2- (2-hydroxy-3-propylamino-
propoxy) -phenyl) -propan-1-one hydrochloride; Positive control – biofilm 
production in medium without tested compound; 0 – no biofilm production; 
1 – weak biofilm production; 2 – moderate biofilm production; 3 – strong 
biofilm production
Effect of ortho-fluorinated propafenone 
derivatives on the Pseudomonas aeruginosa 
pyocyanin production
Ortho-fluorinated propafenone derivatives, 5CF3 and 
5OF, inhibited production of pyocyanin in Pseudomonas 
aeruginosa. In the presence of 500 μg/ml 5OF or 5CF3 
Petrović S. et al.
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production of pyocyanin was reduced to less than 40% of 
the control value in 6/9 strains, and less than 50% of the 
control in 7/9 strains, respectively. In the presence of 250 
µg/ml 5OF or 5CF3, most strains had pyocyanin produc-
tion above 50% of the control value. The difference in the 
sensitivity to the tested compounds among various strains 
was also detected. Results of inhibitory action of 5OF and 
5CF3 on the pyocyanin production in Pseudomonas aeru-
ginosa are expressed as the percentage of the absorbance 
of positive controls (presented as 100% ± SD) (Table 3). 
Table 3. In vitro effect of ortho-fluorinated propafenone derivatives 
5OF and 5CF3 on the production of pyocyanin in Pseudomonas ae-
ruginosa strains 
Parameters 5OF µg/ml 5CF3 µg/ml
500 250 500 250
Pseudomonas 
aeruginosa 
Strain number
Pyocyanin production as% of positive control
1 48.6 70.5 74 79.8
2 27.1 42 36.6 79.8
3 39.3 51.8 68.5 99.4
4 33.7 31.9 34.6 54.2
5 39.4 61.1 48.3 104.9
6 34.3 49.5 35.2 46.6
7 42.7 53.4 51 56.3
8 29.8 54.2 36.9 52.4
ATCC 27853 43.6 57.6 47.9 64
5OF – 3- (2-fluoro-phenyl) -1- (2- (2-hydroxy-3-propylamino-propoxy)  
-phenyl) -propan-1-one hydrochloride; 5CF3 – 3- (2-trifluoromethyl-
phenyl) -1- (2- (2-hydroxy-3-propylamino-propoxy) -phenyl) -propan-1-one 
hydrochloride; Positive control – pyocyanin production of each isolate in the 
absence of the tested compounds (100%).
DISCUSSION
Antibiotic compounds that inhibit different virulence 
factor, such as enterotoxins, hemolysins, biofilm, or pig-
ments, became the focus of the present research [36]. The 
resistance of Pseudomonas aeruginosa isolates to antimi-
crobial drugs is largely attributed to its ability to form a 
biofilm and produce bacterial pigment pyocyanin [37]. In 
this study, we used synthesized propafenone derivatives, 
5CF3, and 5OF, to test inhibitory effect on Pseudomonas 
aeruginosa biofilm and pigment production.
Antimicrobials are generally dedicated to kill bacteria 
(bactericidal) or to inhibited bacterial growth (bacterio-
static). However, mostly due to frequent chromosomal mu-
tations, Pseudomonas aeruginosa appeared to be extremely 
adaptive and acquired resistance to many antibiotics such 
as carbapenems, penicillins and cephalosporins. Recent 
efforts to develop novel class of anti-pseudomonas agents 
moved their focus to Pseudomonas aeruginosa physiol-
ogy and collective behavior of bacterial population [38]. 
Therefore, biofilm formation and its modulation became 
a subject of our research interest. Our results have shown 
that propafenone derivative 5OF and 5CF3 significantly 
reduced biofilm production in all tested isolates of Pseu-
domonas aeruginosa. Previous study on propafenone 
compounds reported antimicrobial effect due to inhibi-
tion of ubiquitous bacterial multidrug efflux pumps [39]. 
Thus, by channel-blocking propafenone may decrease 
drug resistance and positively influence clinical outcome 
of Pseudomonas aeruginosa infections [40]. On the other 
hand, to the best of our knowledge, this study revealed 
identification of ortho-fluorinated propafenone derivatives 
as efficient agents that inhibit Pseudomonas aeruginosa 
biofilm formation for the first time. The inhibitory effects 
of both 5OF and 5CF3 were found. Numerous external fac-
tors affect biofilm formation by Pseudomonas aeruginosa. 
In addition, the type of tissue has strong impact on biofilm 
formation, and researchers commonly test biofilm forma-
tion of Pseudomonas aeruginosa from a variety of clinical 
sources [41]. In our study, various clinical strains showed 
differences in sensitivity to tested compounds, but those 
variations were not connected to specific bacterial source 
(urine, ear swab, sputum). However, we tested only nine 
clinical isolates (5 – urine, 3 – ear swab, 1 – sputum) and 
for such a small number of samples statistical data process-
ing is not relevant.
The highest tested dose of both compounds (500 µg/ml) 
was the most efficient, reducing bacterial growth to the 
highest extent. However, when the concentration of test 
agents decreased bacterial growth recovered. In the pres-
ent study, 5OF was more effective in reducing bacterial 
growth compared to 5CF3. This could be explained by 
higher binding affinity to bacterial transport porin in a 
case of monofluorinated propafenone derivatives (such 
as 5OF), compared to trifluoromethyl derivative (5CF3), 
as found in our docking studies (data not shown) [31]. 
Namely, biofilm formation depends on the presence of an 
extracellular matrix, which is a mixture of polysaccharides, 
proteins, and nucleic acids [extracellular DNA (eDNA)]. 
Matrix polysaccharides (alginate and lipopolysaccha-
rides), which are synthetized in bacterial cytoplasm, bind 
to membrane transporters to be extruded out of the cell 
[42]. It was found that both fluorinated derivatives tested 
in this study briefly occupied key substrate-specific sites in 
the bacterial porin (Arg124). This discovery might be as-
sociated with interruption of the transport of carbohydrate 
compounds involved in synthesis of biofilm [43].
Figure 1. Pseudomonas aeruginosa 
growth on Mueller–Hinton agar
Inhibitory effect of propafenone derivatives on Pseudomonas aeruginosa biofilm and pyocyanin production
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The blue pigment pyocyanin, chemical derivative of 
phenazine, is one of the most important virulence fac-
tors in Pseudomonas aeruginosa [44]. Pyocyanin is toxic 
for respiratory epithelium, it acts on the cell structure and 
function, disrupts normal expression of genes involved in 
efflux pumps, redox homeostasis and iron acquisition in 
human cells [45, 46, 47]. Thus, control of pyocyanin pro-
duction may be a mechanism to reduce bacterial patho-
genicity. Results of our study have shown that both 5OF 
and 5CF3 inhibited production of pyocyanin in all tested 
Pseudomonas aeruginosa isolates. The inhibitory effect was 
concentration dependent, higher concentrations caused 
stronger inhibition, while inhibitory effect decreased with 
lower drugs concentration. Literature survey on other drugs 
suggests that ortho-fluorinated propafenone derivative 5OF 
had significantly stronger inhibitory effect on the produc-
tion of pyocyanin in Pseudomonas aeruginosa strains than 
commercial antibiotics ampicillin or streptomycin. Namely, 
we have shown that lower concentrations of 5OF, 500µg/ml, 
and 250 µg/ml, exerted same or even enhanced inhibitory 
effect compared to commercial antibiotics when applied in 
2–4 times higher concentration (1 mg/ml) [33, 48]. Simi-
larly, the concentrations of 5CF3, which led to pyocyanin 
reduction, were within the same range as concentration of 
standard drugs. The observed propafenone-induced pyo-
cyanin inhibition could be discussed in a view of recent re-
sults on pyocyanin impact on eDNA and biofilm formation 
[11]. It was found that pyocyanin decreases eDNA content 
within the Pseudomonas aeruginosa biofilm. Since eDNA 
promotes bacterial adhesion and cellular aggregation, de-
pletion of eDNA can reduce biofilm strength and disturb 
protection of bacterial cells against antibiotics. Based on the 
aforementioned, it was assumed that reduction of pyocya-
nin production as detected in our study could be a model 
of propafenone derivatives action against Pseudomonas 
aeruginosa pathogenicity and infection. 
CONCLUSION
The results of the study suggest that synthetized ortho-
fluorinated propafenone derivatives inhibit biofilm and 
pyocyanin production in Pseudomonas aeruginosa clinical 
strains. Presented results suggest that propafenone deriva-
tives could be considered as potential lead-compounds for 
synthesis of novel antipseudomonal drugs.
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САЖЕТАК
Увод/Циљ Производња биофилма и пиоцијанина je важан 
фактор вируленције и антибиотске резистенције бактерије 
Pseudomonas aeruginosa. 
Циљ рада је био да се испита инхибиторни ефекат синте-
тисаних пропафенонских деривата, 3-(2-флуоро-фенил)-
1-[2-(2-хидрокси-3-пропиламино-пропокси)-фенил]-про-
пан-1-он-хидрохлорид) (5OF) и 3-(2-трифлуорометилфенил)-
1-[2-(2-хидрокси-3-пропиламино-пропокси)-фенил]-про-
пан-1-он-хидрохлорид) (5CF3), на продукцију биофилма и 
пиоцијанина код клиничких изолата бактерије Pseudomonas 
aeruginosa.
Методе Ефекат пропафенонских деривата испитан је на 
девет клиничких изолата и једном стандардном соју бакте-
рије P. aeruginosa. Утицај на продукцију биофилма испитан 
је in vitro, инкубацијом бактерија (0,5 по Макфарланду) са 
5OF и 5CF3 (500–31,2 µg/ml), и мерењем оптичке густине на 
570 nm. Бактерије у медијуму без испитиваних једињења су 
биле позитивна контрола, а сам медијум негативна контро-
ла. Производени пиоцијанин, који је одређиван мерењем 
оптичке густине на 520 nm, на коинкубације бактерија са 
5CF3 или 5OF (250 и 500 μg/ml), третиран је хлороформом и 
мешањем хлороформског слојa са HCl.
Резултати При концентрацији од 500 µg/ml 5OF је довео до 
потпуне инхибиције продукције биофилма код свих испи-
тиваних сојева (10/10). Инхибиција биофилма са 500 µg/ml 
5CF3 била је потпуна код 4/10 сојева. При концентрацији 
5OF и 5CF3 од 250 µg/ml продукција биофилма код већине 
испитаних изолата била је слаба, док је при концентрацији 
125 µg/ml 5OF односно 5CF3 продукција била умерена. Ниже 
концентрације 5OF и 5CF3 нису имале инхибиторни ефекат 
на формирање биофилма. У присуству 500 μg/ml 5OF у 6/10 
испитиваних сојева продукција пиоцијанина пала је на мање 
од 40% у односу на контролну вредност. Иста концентрација 
(500 μg/ml) 5CF3 снизила је продукцију пиоцијанина на мање 
од 50% од контроле у 7/9 сојева. При концентрацији 250 µg/
ml 5OF или 5CF3 већина сојева продуковала је пиоцијанин 
изнад 50% у односу на позитивну контролу.
Закључак Синтетисани пропафенонски деривати, 5OF и 
5CF3, инхибирају продукцију биофилма и пиоцијанина код 
клиничких сојева бактерије Pseudomonas aeruginosa. До-
бијени резултати указују на то да пропафенонски деривати 
представљају могућа полазна једињења за синтезу нових 
антипсеудомонасних агенаса.
Kључне речи: пропафенонски деривати; Pseudomonas 
aeruginosa; биофилм; пиоцијанин
Инхибиторни ефекат пропафенонских деривата на продукцију биофилма  
и пиоцијанина код бактерије Pseudomonas aeruginosa
Сњежана Петровић1, Јасмина Башић2, Зоран Мандинић3, Драгана Д. Божић4, Марина Миленковић4, Зорица Вујић5
1Универзитет у Београду, Институт за медицинска истраживања, Центар изузетне вредности у области истраживања исхране и 
метаболизма, Београд, Србија; 
2Висока здравствена школа струковних студија у Београду, Земун, Србија;
3Универзитет у Београду, Стоматолошки факултет, Клиника за дечју и превентивну стоматологију, Београд, Србија;
4Универзитет у Београду, Фармацеутски факултет, Катедра за микробиологију и имунологију, Београд, Србија;
5Универзитет у Београду, Фармацеутски факултет, Катедра за фармацеутску хемију, Београд, Србија
Petrović S. et al.
DOI: https://doi.org/10.2298/SARH180727102P
